Browsing by Author Tsimihodimos, V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 9 to 28 of 74 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinicLiamis, G.; Tsimihodimos, V.; Doumas, M.; Spyrou, A.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particlesGazi, I. F.; Tsimihodimos, V.; Tselepis, A. D.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implicationsTsimihodimos, V.; Kakaidi, V.; Elisaf, M. S.24-Nov-2015-
Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolismAgouridis, A. P.; Filippatos, T. D.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemiaLiamis, G.; Kakafika, A.; Bairaktari, E.; Miltiadous, G.; Tsimihodimos, V.; Goudevenos, J.; Achimastos, A.; Elisaf, M. S.24-Nov-2015-
Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemiaMiltiadous, G.; Bairaktari, E.; Tzallas, C.; Tsimihodimos, V.; Liberopoulos, E.; Millionis, H.; Rizos, E.; Elisaf, M. S.24-Nov-2015-
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteriaGazi, I.; Tsimihodimos, V.; Filippatos, T.; Bairaktari, E.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Disturbances of phosphate metabolism: another feature of metabolic syndromeKalaitzidis, R.; Tsimihodimos, V.; Bairaktari, E.; Siamopoulos, K. C.; Elisaf, M. S.24-Nov-2015-
Does micronized fenofibrate affect PAF-Acetylhydrolase activity?Elisaf, M. E.; Tsimihodimos, V.; Bairaktari, E.; Tambaki, A.; Tselepis, A.; Papathanasiou, A.; Goudevenos, I.24-Nov-2015-
Dyslipidemia associated with chronic kidney diseaseTsimihodimos, V.; Mitrogianni, Z.; Elisaf, M. S.24-Nov-2015-
Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatmentTsimihodimos, V.; Dounousi, E.; Siamopoulos, K. C.24-Nov-2015-
Editorial: secondary dyslipidemiasElisaf, M. S.; Tsimihodimos, V.24-Nov-2015-
Effect of atorvastatin on serum uric acid levelsKakafika, A.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A.; Bairaktari, E.; Achimastos, A.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein sulafractions in patients with dyslipidemias of type IIA and IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A.; Bairaktari, E.; Achimastos, A.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymesRizos, E.; Bairaktari, E.; Ganotakis, E.; Tsimihodimos, V.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Filippatos, T.; Saougos, V.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of Ezetimibe on Lipoprotein Subfraction Concentrations: The Role of Atorvastatin PretreatmentTsimihodimos, V.; Kalogirou, M.; Lagos, K.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Effect of ezetimibe on lipoprotein subfractions in patients with primary dyslipidemiasKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on LDL subfractions in patients with combined dyslipidemiaTsimihodimos, V.; Irene, G.; Tselepis, A.; Bairaktari, E.; Elisaf, M.24-Nov-2015-